Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tatiana Lawrence"'
Autor:
Lucas Moreno, Pierre Teira, James M. Croop, Nicolas U. Gerber, Nicolas André, Isabelle Aerts, Luis Gros Subias, Bram De Wilde, Francisco Bautista, Brian Turpin, Srinivasa Kunduri, Ali Hamidi, Tatiana Lawrence, Keri A. Streby
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundThe survival rates for pediatric patients with relapsed and refractory tumors are poor. Successful treatment strategies are currently lacking and there remains an unmet need for novel therapies for these patients. We report here the results
Externí odkaz:
https://doaj.org/article/f28a1250c8b1469e8458cf378d213834
Autor:
Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, Tatiana Lawrence, Jennifer Schenfeld, Prasad L. Gawade
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
Abstract Background Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), is commonly used to prevent febrile neutropenia (FN), a potentially life-threatening complication, following myelosuppressive chemotherapy. The FDA label
Externí odkaz:
https://doaj.org/article/1b326982c9d54f28ab74259e0e246318
Autor:
Ran Jin, Reshma L. Mahtani, Neil Accortt, Tatiana Lawrence, Darcie Sandschafer, Arturo Loaiza-Bonilla
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: In July 2019, bevacizumab-awwb and trastuzumab-anns were marketed in the USA as the first therapeutic oncology biosimilars. We aimed to investigate the initial real-world use of bevacizumab-awwb and trastuzumab-anns for cancer management
Externí odkaz:
https://doaj.org/article/c28366945e0149f1b1257241f26196e0
Autor:
Robert M. Rifkin, Jeffrey Crawford, Reshma L. Mahtani, David C. Dale, Mohit Narang, William W. MacLaughlin, Chanh Huynh, Prasad L. Gawade, Sandra Lewis, Lucy DeCosta, Tatiana Lawrence, Rajesh Belani
Publikováno v:
Supportive Care in Cancer. 30:7913-7922
Purpose We evaluated the incidence of febrile neutropenia (FN) and related clinical outcomes among patients treated with myelosuppressive chemotherapy for nonmyeloid malignancies who received pegfilgrastim on-body injector (OBI) or other options (Oth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02e5ef905d5a87fff54d19ae94b624ad
https://doi.org/10.1007/s00520-022-07226-9
https://doi.org/10.1007/s00520-022-07226-9
Autor:
Reshma L. Mahtani, Rajesh Belani, Jeffrey Crawford, David Dale, Lucy DeCosta, Prasad L. Gawade, Chanh Huynh, Tatiana Lawrence, Sandra Lewis, William W. MacLaughlin, Mohit Narang, Robert Rifkin
Publikováno v:
Supportive Care in Cancer. 30:6135-6144
Background Breast cancer chemotherapy often carries a high risk of febrile neutropenia (FN); guidelines recommend prophylaxis with granulocyte colony-stimulating factor (G-CSF), such as pegfilgrastim. Neulasta® Onpro® on-body injector (OBI) is a de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a4abec659472d32d2c331fd748c53d
https://doi.org/10.1007/s00520-022-07025-2
https://doi.org/10.1007/s00520-022-07025-2
Autor:
James B. Bussel, Nichola Cooper, Tatiana Lawrence, Marc Michel, Emilie Vander Haar, Kejia Wang, Hongmei Wang, Hossam Saad
Publikováno v:
American journal of hematologyREFERENCES. 98(1)
Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the lack of fetal safety evidence of maternally-administered medications. The Pregnancy Surveillance Program (PSP) collected patient information from 2017-2020 for pregnancy, bir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba6c7537c507512ea7fede610e14b86
https://pubmed.ncbi.nlm.nih.gov/36156812
https://pubmed.ncbi.nlm.nih.gov/36156812
Autor:
Adriana Balduzzi, Gerald A. Soff, James B. Bussel, Tatiana Lawrence, Nichola Cooper, John W. Semple
Publikováno v:
Drug Design, Development and Therapy
Thrombocytopenia results from a variety of conditions, including radiation, chemotherapy, autoimmune disease, bone marrow disorders, pathologic conditions associated with surgical procedures, hematopoietic stem cell transplant (HSCT), and hematologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63f09453b3a61929016cbbe21347513
http://europepmc.org/articles/PMC8165097
http://europepmc.org/articles/PMC8165097
Autor:
Reshma Mahtani, Alan Brookhart, Robert Rifkin, Jeffrey Crawford, Prasad L. Gawade, Rajesh Belani, Sandra Lewis, Gary H. Lyman, Tatiana Lawrence, David C. Dale
Publikováno v:
Cancer Research. 81:PS9-50
Background Pegfilgrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) shown to effectively reduce the risk of chemotherapy-induced FN. Pegfilgrastim should be administered on the day after chemotherapy completion (Lyman, Cancer, 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58e8de6e5bbd191e5de532a215ad174f
https://doi.org/10.1158/1538-7445.sabcs20-ps9-50
https://doi.org/10.1158/1538-7445.sabcs20-ps9-50
Autor:
Gary H. Lyman, Mark Hatfield, Devi Sundaresan, Ahuva Averin, Manpreet Kaur, Amanda Silvia, Derek Weycker, Tatiana Lawrence, Kathryn Richert-Boe, Neel Shah, Lois Lamerato
Publikováno v:
Supportive Care in Cancer
Objectives To evaluate the use of granulocyte colony-stimulating factor (G-CSF) prophylaxis in US patients with selected metastatic cancers and chemotherapy-induced febrile neutropenia (FN) incidence and associated outcomes among the subgroup who did
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d80812eae128cfaccbca724620510d5
http://europepmc.org/articles/PMC7892737
http://europepmc.org/articles/PMC7892737
Autor:
Prasad L. Gawade, Reshma Mahtani, Jeffrey Crawford, Tatiana Lawrence, Jennifer Schenfeld, Sinéad M. Flannery
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-19 (2021)
Background Pegfilgrastim, a long-acting granulocyte colony-stimulating factor (G-CSF), is commonly used to prevent febrile neutropenia (FN), a potentially life-threatening complication, following myelosuppressive chemotherapy. The FDA label for pegfi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f84dfd9864fa3832c13b9d3ee9eea5c
https://pubmed.ncbi.nlm.nih.gov/34044798
https://pubmed.ncbi.nlm.nih.gov/34044798